Antibodies against CD14 protect primates from endotoxin-induced shock

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1533-1538

  Leturcq, Didier J ^a   Moriarty, Ann M ^a   Talbott, Greg ^b   Winn, Robert K ^b   Martin, Thomas R ^c   Ulevitch, Richard J ^d  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

acute lung injury; antigens, CD14; lipopolysaccharides; primates; shock

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; MONKEY; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0029848826     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118945     Document Type: Article

References (32)

1. Martin, M.A., and H.J. Silverman. 1992. Gram-negative sepsis and the adult respiratory distress syndrome. J. Infect. Dis. 14:1213-1228.
2. Parillo, J.E., M.M. Parker, C. Natanson, A.F. Suffredini, R.L. Danner, R.E. Cunnion, and F.P. Ognibene. 1990. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113:227-242.
3. Luderitz, O., K. Tanamoto, C. Galanos, G.R. McKenzie, H. Brade, U. Zahringer, E.T. Rietschel, S. Kusumoto, and T. Shiba. 1984. Lipopolysaccharides: structural principles and biologic activities. Rev. Infect. Dis. 6:428-431.
4. Tobias, P.S., K. Soldau, and R.J. Ulevitch. 1986. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164:777-793.
5. Schumann, R.R., S.R. Leong, G.W. Flaggs, P.W. Gray, S.D. Wright, J.C. Mathison, P.S. Tobias, and R.J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science (Wash. DC). 249:1429-1431.
6. Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (Wash. DC). 249:1431-1433.
7. Bazil, V., M. Baudys, I. Hilgert, I. Stefanova, M.G. Low, J. Zbrozek, and V. Horejsi. 1989. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol. Immunol. 26:657-662.
8. Frey, E.A., D.S. Miller, T.G. Jahr, A. Sundan, V. Bazil, T. Espevik, B.B. Finlay, and S.D. Wright. 1992. Soluble CD14 participates in the response of cells to lipolysaccharide. J. Exp. Med. 176:1665-1671.
9. Pugin, J., C.-C. Shurer-Maly, D. Leturcq, A. Moriarty, R.J. Ulevitch, and P.S. Tobias. 1993. Lipolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA. 90:2744-2748.
10. Viriyakosol, S., and T.N. Kirkland. 1995. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270:361-368.
11. Lee, J.-D., V. Kravchenko, T.N. Kirkland, J. Han, N. Mackman, A. Moriarty, D. Leturcq, P.S. Tobias, and P.S. Ulevitch. 1993. Glycosylphosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc. Natl. Acad. Sci. USA. 90:9930-9934.
12. Eden, E., and G.M. Turino. 1986. Interleukin-1 secretion by human alveolar macrophages stimulated with endotoxin is augmented by recombinant immune (Gamma) interferon. Am. Rev. Respir. Dis. 133:455-460.
13. Heinzel, F. 1990. The role of IFN-γ in the pathology of experimental endotoxemia. J. Immunol. 145:2920-2924.
14. Kohler, J., D. Heumann, G. Garotta, D. LeRoy, S. Bailat, C. Barras, J.-D. Baumgartner, and M.P. Glauser. 1993. IFN-γ involvement in the severity of gram-negative infections in mice. J. Immunol. 151:916-921.
15. Mathison, J.C., E. Wolfson, and R.J. Ulevitch. 1988. Participation of tumor necrosis factor in the mediation of gram-negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81:1925-1937.
16. Rosner, B. 1982. Fundamentals of Biostatistics. Duxhury Press. Boston, MA.
17. Martich, G.D., A.J. Bougoukos, and A.F. Suffredini. 1993. Response of man to endotoxin. Immunobiolagy. 187:403-416.
18. Natanson, C., W.D. Hoffman, A.F. Suffredini, P.Q. Eichacker, and R.L. Danner. 1994. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120:771-783.
19. Car, B.D., V.M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437-1444.
20. Holter, J.F., J.E. Weiland, E.R. Pacht, G.E. Gadek, and W.B. Davis. 1986. Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J. Clin. Invest. 78:1513-1522.
21. Bachofen, M., and E.R. Weibel. 1982. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med. 3:35-56.
22. Boujuukos, A.J., G.D. Martich, E. Supinski, and A.F. Suffredini. 1993. Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. J. Appl. Physiol. 74:3027-3033.
23. Weiland, J.E., W.B. Davis, J.F. Holter, J.R. Mohammed, P.M. Dorinsky, and J.E. Gadek. 1986. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am. Rev. Respir. Dis. 133: 218-225.
24. Steinberg, K.P., J.A. Milberg, T.R. Martin, R.J. Maunder, B.A. Cockrill, and L.D. Hudson. 1994. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care. Med. 150:113-122.
25. Danner, R.L., R.J. Elin, J.M. Hosseini, R.A. Wesley, and J. Parillo. 1991. Endotoxemia in human septic shock. Chest. 99:169-175.
26. Parsons, P.E., G.S. Worthen, E.E. Moore, R.M. Tate, and P.M. Henson. 1989. The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140:294-301.
27. Michie, H.R., K.R. Manogue, D.R. Spriggs, A. Revhaug, S. O'Dwyer, C.A. Dinarello, A. Cerami, S.M. Wolff, and D.W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
28. Suffredini, A.F., R.E. Fromm, M.M. Parker, M.B. Brenner, J.A. Kovacs, R.A. Wesley, and J.E. Parrillo. 1989. The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321:280-287.
29. Taveria da Silva, A.M., H.C. Kaulbach, F.S. Chuidian, D.R. Lambert, A.F. Suffredini, and R.L. Danner. 1993. Brief report: shock and multiple-organ failure after self-administration of Salmonella endotoxin. N. Engl. J. Med. 328: 1457-1460.
30. Ziegler, E.J., C.J. Fisher, C.L. Sprung, R.C. Straube, J.C. Sadoff, G.E. Foulke, C.H. Wortel, M.P. Fink, P. Dellinger, N.N.H. Teng, et al. 1991. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 324:429-436.
31. Pugin, J., I.D. Heumann, A. Tomasz, V.V. Kravchenko, Y. Akamatsu, M. Nishijima, M.P. Glauser, P.S. Tobias, and R.J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity. 1:509-516.
32. Wright, S.D. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155:6-8.